New Strain of Group A Strep Bacteria Discovered by UK Investigators
The team identified a new strain type within the emm1 bacteria group, which differed from the other emm1 strains by 27 genetic mutations.
FDA Warns of Scombroid Poisoning Link to Fish Sold at Kroger
Several cases of scombroid poisoning were reported on September 4, 2019, among individuals who consumed tuna steaks purchased from 3 different Kroger retail stores in Ohio.
WHO Updates Guidelines for Contraceptive Use in Women with High HIV Risk
There was no difference in HIV acquisition among women who used progestogen-only injectables, implants, or intrauterine devices.
Doxycycline Prophylaxis an Effective Option for Bacterial STIs
In the doxycycline as PrEP arm, there was a 73% reduction (p = .02) in syphilis, Neisseria gonorrhoeae, and Chlamydia trachomatis infections.
Antibiotic Alerts: Building Better Processes to Encourage Stewardship
An automatic, built-in alert shows promise in helping to de-escalate antibiotic use at a large community teaching hospital.
Ebola Survivors Experience Increased Mortality Risk in Year Following Recovery
Investigators observed that, when compared with the general population of Guinea, survivors of Ebola had a 5-fold increased risk of mortality over a mean of 1 year of follow-up after discharge.
New HIV Diagnoses in UK Declined by 28% Since 2015
In 2018, the UK recorded 4484 new cases of HIV, representing a 28% decrease compared with the 6271 new diagnoses documented in 2015.
FMT Decreases Antimicrobial Resistance in Study of Children with C diff
A new study using shotgun metagenomic sequencing found that FMT yielded a sustained decrease in antimicrobial resistance genes and potential pathogens in children with recurrent C diff.
Successful Antimicrobial Stewardship Takes Team Approach
A new article aims to help health care organizations set up antimicrobial stewardship programs based on sound scientific evidence.
The ID Pipeline: FDA Activity From the Week of September 1, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of September 1, 2019.
Recalls That Should Be on Your Radar—Week of September 1, 2019
We’ve rounded up a list of important US Food and Drug Administration (FDA) and US Department of Agriculture (USDA) recalls from this past week.
Top Infectious Disease News of the Week—September 1, 2019
Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.
Daily PrEP vs Non-Daily PrEP: Does It Matter?
That daily PrEP dose may not be necessary, according to a new study that examined time-driven and event-driven dosing in a high-risk population.
Can Mefloquine Be Repurposed as an Antifungal?
Researchers have hypothesized that the amount of time required to develop a novel antifungal therapeutic can be cut by repurposing drugs that are already FDA approved.
Chloroquine and Primaquine Show Promise in Controlling Cryptococcus Growth
Cryptococcal meningitis is the leading cause of mortality in people living with HIV/AIDS, but a new study shows promising results for alternative treatments.
As Hurricane Season Begins, Officials Prepare for Potential Outbreaks
Natural disasters like hurricanes can have implications for public health, including a heightened risk of infectious diseases.
Novel Bacteriocin a Promising New Treatment for Resistant Listeria monocytogenes
Bacteriocin operates effectively by damaging the cell walls of the target species, inducing cell perforation and blebbing, thus killing the cells.
OASIS Pooled Results: Omadacycline Safe and Efficacious in IVDU and non-IVDU
Investigators have presented the microbiological, efficacy, and safety results in the pooled intravenous drug use vs non-intravenous drug use patients in 2 phase 3 ABSSSI studies, OASIS-1 and 2.
A Potential Treatment Option for Multidrug-Resistant Gonorrhea
The in vitro activity of nano-mupirocin, as well as its distribution to vaginal mucus, strongly support its development for the treatment of MDR gonorrhea.
C Diff and Fungi: An Unexpected Partnership
A new study sheds light on the relationship between fungi and C diff infections.
Measles Vaccination Attitudes Could Be Swayed by Outbreak Proximity
Being geographically close a measles outbreak could change the way individuals feel about getting vaccinated against the disease.
Rethinking How New Antibiotics for Resistant Infections Are Approved: Public Health Watch
Adding post market adaptive studies to existing noninferiority trials can provide clinicians with necessary data without slowing market introduction.
Baloxavir Marboxil Shows Promise in 2 Phase 3 Studies
The MINISTONE-2 study enrolled pediatric patients and the BLOCKSTONE study looked at preventive treatment for individuals living with someone with an influenza infection.
Inappropriate Treatment for Asymptomatic Bacteriuria Is Common, Risky
Prescriptions are often given for antimicrobial treatment for asymptomatic bacteriuria despite national guidelines against it, which could lead to longer hospital stays, a new study found.
Study Reveals Gaps in Mumps Immunity Among Vaccinated Individuals
A new study of college-aged individuals demonstrated insufficient immunity in a fraction of participants who were vaccinated against mumps in childhood.
Why We Need More Open-Source Epidemiological Tools
A newer software called STEM offers an accessible, customizable tool for outbreak response and preparedness efforts.
An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban Outbreak
Although Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
FDA Activity Tracker: Top Approvals of 2019 to Date
As the summer comes to a close, our editorial team is looking back at the top FDA approvals of 2019 to date and looking ahead at what is left on the docket this year.
EEE Threat Level Raised in Massachusetts Following First Fatality
The total number of communities at critical risk of the mosquito-borne Eastern equine encephalitis stands at 28 statewide. Thirty-seven other towns are considered at high risk for EEE, while 126 are at moderate risk.
The ID Pipeline: FDA Activity From the Week of August 25, 2019
Here is a look at infectious disease-related US Food and Drug Administration news from the week of August 25, 2019.